FDA NDC Directory · JSON-LD · Markdown

INFLIXIMAB

NDC 57894-160 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA103772
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsINFLIXIMAB (100 mg/10mL)
Marketing started20211005
Package count1

External sources

Source: openFDA. Public-domain (CC0).